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     Since esophagus cancer is among the most fatal cancers all over the world and our country has the 
most frequent number of patients, identification of squamous cell carcinoma associated proteins would 
be essential. Finding molecular markers for recognition of the disease could be beneficial for efficient 
and early treatment of the disease. As protein expression in cancerous cells is different from normal 
ones, identification of protein expression pattern could be helpful for recognition of the disease. 
Proteomics is a novel method for recognition of protein collection in a specific tissue. In this method 2D 
gel electrophoresis is performed to separate all proteins, and then spot analysis will be done through 
mass spectrometry and bioinformatics software would help in the recognition of proteins. In comparison 
to normal tissue in cancerous cells, we would have up-regulation, down-regulation, appearance or 
disappearance of a specific protein. So, protein extraction was performed from healthy and cancerous 
mucosal tissue of esophagus and all peptides were separated through 2D gel electrophoresis. After spot 
analysis, proteins with different expression were identified with mass spectrometry and bioinformatics. 
In comparison to normal tissue, 14 proteins were found to over expressed or have no expression in 
tumors.  The main objective of this study is that proteomics is an ideal method to find the 
molecular basis of squamous cell carcinoma in esophageal cancer. 
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INTRODUCTION  
     Cancer is defined as uncontrolled 
proliferation of cells. This phenomena is arises 
from genetic changes and would cause normal 
tissue damage, metastasis, migration and 
establishing new tumors in different tissues [1]. 
Cancer results from genetic damages [2]. 
     In cancer, different chromosomal disorders 
happen which result in genetic changes. In 
addition, many environmental factors can 
increase genetic damage and cancer risk, such 
as inflammatory reactions, chemical 
stimulations, and physical blows and infectious 
microorganisms.  
 Two essential groups of genes are very 
important in genetic changes and damages: 
 
1) Cellular oncogenes (or proto-oncogenes), and 
2) Antioncogenes (or tumor suppressor genes) 
[3].  
Oncogenes are effective in cell growth and 
proliferation and tumor suppressor genes 
regulate or limit cell proliferation. These genes 
can effect cell proliferation, induction of 
differentiation regulation of cell to cell contacts 
and senescence induction or apoptosis [4, 5]. 
     In all kinds of cancers, tumor suppressors are 
inactivated so inactivation of suppressors has 
effective role in initiation and progress of the 
disease [6]. 
     Activation of oncogenes and deactivation of 
suppressor genes is the effect of chemical 
carcinogens [7], chromosomal changes [8], 
viruses [9] and their products. For example, 
activation of myc or ras, myb or erb-B 
oncogenes or inactivation of tumor suppressor 
genes as p53, Rb, MCC and DCC are the 
consequence of chemical carcinogens [10]. 
Tumorogenesis is a multistage process that 
includes initiation [11], promotion [12], 
progression [13], and metastasis [14].Every 
stage has its specific genetic and epigenetic 
damages and leads to make malignancy and 
invasion. 
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     Metastasis includes growth, angiogenesis, 
and invasion. Without access to blood, tumors 
can not grow more than several millimeters, so 
tumor cells produce angiogenesis factors, digest 
outer cellular spaces, enter to circulation , 
connect to basal endothelial membranes and 
exit from lymphatic system  and vessels, and to 
complete metastasis they digest extracellular 
matrix and immigrate to mesenchymal matrix 
and deposit angiogenesis factors [15]. Tumor 
made vascular system is not like normal vessels 
and it helps for better invasion to vascular 
system. During transmission in vascular system, 
tumor cells can connect to each other through 
adhesive specificity and clump up. Sometimes 
WBCs are also added to this collection to 
protect it.  On the other hand, this clump will 
initiate metastasis. 
     Esophagus cancer is the sixth cancer in the 
world and the fourth in developing countries 
[16]. It usually happens in middle ages or older 
but it could occur in people younger than 25 
years old. The disease is more common in men 
than women and more in black people than 
whites. Incident frequency is quite different all 
over the world. Environmental factors could 
have an impact on disease occurrence. Previous 
studies showed that China and Iran have high 
risk in disease incidence. Torkman Sahra and 
Gonbad in Iran have the most frequency of 
esophagus cancer and China with 65% of 
occurrence is in the second stage. Also 70% of 
all cases in the world belong to Iran [17]. In 
molecular studies, proteomics is a method for 
proteome recognition in different organisms.  
Proteome is the collection of proteins that are 
produced by each organism. 
     Each specific species has its own constant 
genome, but proteome changes from time to 
time in different stages of life. So, proteome is 
the collection of specific proteins in a specific 
life stage of each organism. On the other hand, 
genome is only the recipe of producing proteins 
but proteins perform special cell functions. 
Also, different cells have different proteins. All 
of the cells in a body have the same genome 
sequence but activation of different genes in 
various sorts of tissues produce broad kinds of 
proteins.  Also tumor cells produce proteins 
other than normal tissue, so recognition of the 
entire human proteome and protein –protein 
interactions would guide us to know molecular 
basis of the diseases and produce more effective 
drugs. 
     In human genome project, 3 billion DNA 
base pairs, especially protein coding sequences 
were recognized. To some extent it is possible 
to predict protein sequence from genome 
sequence, but proteome is more complicated 
than genome.  On the other hand, proteins have 
different functions in different environments 
because some proteins are active in aqueous 
environment but others are hydrophobous. 
Researchers believe that human genome has 40 
thousand genes but 100 thousand proteins are 
being built. Proteome provides us with 
information about specificities of all these 
proteins in translation stage and post 
translational modification level and also about 
protein – protein interactions [18]. 
So, in conclusion: 
1. DNA sequences are constant map of 
biochemical pathways. 
2. DNA sequence can not show changes and 
post translational modifications such as splicing 
and translational modifications as 
phosphorylation, glycosilation and other 
essential changes that make a protein functional. 
3. Most of the time, genome remains intact but 
proteins can change due to induction or 
suppression of different genes [19]. 
4. Our knowledge about genome sequence can 
not lead to protein recognition, we can use 
genome only for ORF prediction, but it's not 
accurate. 
5. We can not predict protein action by its DNA 
sequence. 
6. We can not predict number of proteins which 
may be being built by a gene. 
 
MATERIALS AND METHODS 
 
Patients and tissue sampling 
Cancerous and normal tissue specimens were 
collected from 45 patients with SCCE who 
underwent surgery. Tissue samples were 
collected immediately after surgery, wrapped in 
aluminum foil, snap frozen in liquid nitrogen 
and maintained at -70°C. The age of the patients 
at the time of diagnosis ranged from 27 to 86 




100-150 mg of tissue was sliced on ice and 
pulverized under liquid nitrogen using a 
microdismemberator (Braun, Germany). 
Subsequently 600 μl homogenization buffer was 
added to the pulverized tissues, mixed and 10 μl 
of the following protease inhibitors were added: 
Pepestatin (1mg/mL in isopropanol), 
benzamidine (16mg/mL in H2O), 
phenylmethylsulphonyl fluoride (PMSF at 
25mg/mL in isopropanol). To this homogenate, 
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10μl of RNase A (10mg/ml in homogenization 
buffer) and DNase I (1mg/ ml in 
homogenization buffer) were added and 
incubated on ice for 20min. Subsequently, urea 
at 7mol/l, thiourea at 2mol/L, 5% ß-
mercaptoethanol and 0.5% SDS were gradually 
added and the volume of solution was adjusted 
to 1.5ml with the homogenization buffer. 
Samples were centrifuged at high speed for 
removal of insoluble particles [20] and 5μl of 
each was used for protein concentration 
assessment using the Bradford assay. [21] 
 
Two-dimensional electrophoresis 
Samples were subjected to isoelectrofocusing 
(IEF) following adaptations and slight 
modification [22]. The first dimension gel was 
composed of 4.2% acrylamide, 0.27% (V/V) 
Nonidet P-40 (NP-40), 5% sucrose and 6% 
ampholytes (pH 4-6, 5-7 and 6-8 at a ratio of 
2:1:2, respectively) and 0.05% TEMED (N, N, 
N’, N’- Tetamethylethylene diamine). The 
solution was degassed and 0.04% ammonium 
persulfate was added, mixed and poured to a 
height of 130 mm in cylindrical glass tubes with 
a 1.5 mm internal diameter. A volume of 
sample equal to 75 μg total protein was mixed 
with 0.33 volume of neutralizing buffer (9 mol/l 
urea, 8% NP-40 and 5% ampholytes pH 3.5-
10), loaded on IEF gel, overlaid with10 μl 
sample buffer (4 mol/l urea, 1% ampholytes pH 
3.5-10) and filled with catholyte. The upper 
chamber buffer or catholyte was composed of 
extensively degassed 0.02mol/l NaOH and the 
lower chamber buffer or anolyte; 0.01mol/L 
phosphoric acid. Isoelectric focusing was 
applied, without prefocusing, at 300 V for 1 h, 
afterward at 600 V for 10 h and 800 V for 1 h in 
order to complete focusing. Gels were removed 
and equilibrated for 20 min at room temperature 
in equilibration solution (60mmol/l Tris-HCl, 
pH 6.8, 2% SDS, 5% β- mercaptoethanol (V/V), 
10% glycerol (V/V), and 0.002% bromophenol 
blue). The second dimension gel consisted of 
33.3 ml of 30% stock acrylamide solution and 
N, N’-methylene bisacrylamide(29.2% and 
0.8% W/V respectively), 41.7 ml de-ionized 
water and 25 ml separation gel buffer (1.5mol/l 
Tris- HCl, pH 8.8, 0.4% SDS [Sodium Dodecyl 
Sulfate]), 0.034% W/V) ammonium persulfate 
and 0.05% TEMED. The (equilibrated first 
dimension gel was layered on the second 
dimension gel and fixed in place with 1% 
agarose and electrophoresis was carried out at 
30 mA/plate at 10°C constant temperature by 
applying a cooling system.[23] 
 
Protein detection 
Proteins were detected using a slight 
modification of the previously reported method 
[24]. The gel was fixed (methanol, water, acetic 
acid and formaldehyde: 50/38/12/0.05 per 
volume) for at least 1h with constant shaking 
and followed by 3 20 min washes with 50% 
ethanol, pretreated with sodium thiosulfate 
(Na2S2O3.5H2O; 0.2g/l) for 1 min, and washed 
three times each for 20s with ddH2O. 
Impregnation of the gel with AgNO3 (1.9 g/l 
and 0.075% (V/V) of 37% formaldehyde) was 
carried out and the residual AgNO3 was 
removed by 3 × 20s successive washes with de-
ionized water. The gel was developed by 
soaking it in developing solution containing 
Na2CO3 (60g/L), 0.05% (V/V) of 37% 
formaldehyde and 4mg/l of Na2S2O3.5H2O for 
10min. up until it appeared to develop yellowish 
brown spots. The gel was then rinsed twice, 
each for 2min, with ddH2O. Further 
development was stopped by immersing the gel 
in stop solution (50% methanol and 12% acetic 




Silver stained protein spots containing the 
proteins of interest were de-stained thoroughly 
with 1% H2O2 (typically 1min) and lyophilized 
to dryness. Silver stain removal by matrix-
assisted laser desorption/ionization time-offlight 
mass spectrometry (MALDI). The dehydrated 
gel bands were hydrated with 15μg/l (Promega, 
Madison, WI) of porcine trypsin in 25mmol/l 
NH4HCO3, pH8.2 on ice for 45min. Excess 
trypsin was removed; gel bands were covered 
with 25mmol/l NH4HCO3, pH8.2 and incubated 
at 37°C overnight. Tryptic peptides were 
extracted from the gel bands with 70% 
acetonitrile and0.1% trifluoroacetic acid. 
Samples were desalted with C18 Zip Tips 
(Millipore, Bedford, MA) as per manufacturer's 
protocols. 0.5μl of sample was co-crystallized 
with0.5μl of α-cyano-4-hydroxycinnamic acid 
in 50% acetonitrile, 1% trifluoroacetic acid and 
spotted directly on a stainless steel MALDI 
target plate. Mass spectra were acquired using a 
MALDI-TOF/TOF mass spectrometer (Voyager 
4700, Applied Biosystems, Foster City, CA). 
MALDI-TOF/TOF spectra were internally 
calibrated (<20ppm) using trypsin autolysis 
products. Post-acquisition baseline correction 
and smoothing was carried out using software 
provided with the TOF/TOF instrument. Spectra 
were submitted to Mascot 
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Identification of poly peptides 
     For every sample 2 different 2D gel 
electrophoresis were performed and tumoral 
tissue was compared with its own normal tissue. 
Position, size and intensity of every spot were 
compared in tumoral and normal tissue, and 
also with other samples. Making comparison 
based on existence or elimination of spots and 
also increase or decrease of spot intensity was 
performed and differences between normal and 
malignant tissue of the same origin were 
recorded in table. 
     In addition, as a final record, spots which 
had been changed (elimination, existence or 
change in size) in more than 70% of gels were 
recorded. Studies have been performed on 30 
samples of normal and tumoral tissues from 11 
women and 19 men aged between 23-73 (mean 
58 years old). 
       All tumors were metastatic and included 
different tissues from mucosa to serous. 
Cellular differentiation in different patients was 
recognized as, 7 patients were well, 4 were 
moderate and 14 were poor.  
 
Comparing protein expression in normal and 
tumoral tissues 
     There are two methods for the study of 
polypeptides and changes in expression levels, 
one, using software to count and compare every 
spot in normal and tumoral tissue of the same 
specimen, which is more accurate and correct.  
The second method is finding different spots 
and their changes by watching them and 
recording changes. In comparison with tumoral 
and normal tissues, spots with more than 70% 
changes were recognized and recorded. 
14 spots in tumoral tissue were recognized 
which had changed drastically, from these 
counts, 7 spots existed or had increased 
expression levels and 7 spots were eliminated or 
had decreased expression level (Tables 1). 
 










Normal Disappearance 5.5/40.3 A 
Normal Down Regulation 5.45/17.6 B 
Normal Down Regulation 5.6/17.6 C 
Normal Down Regulation 5.8/17.6 D 
Normal Down Regulation 6.08/17.6 E 
Normal Down Regulation 6.6/76 F 
Normal Down Regulation 7.3/35.5 H 
Tumor Up Regulation 6/64 1 
Tumor Up Regulation 5.5/32.8 2 
Tumor Up Regulation 5.4/20.1 3 
Tumor Up Regulation 6.9/42.4 4 
Tumor Up Regulation 6.1/27.2 5 
Tumor Up Regulation 6.1/27.2 6 
Tumor Up Regulation 6.1/27.2 7 
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     In figures 1 and 2, there are 2 gels from 
normal and tumoral tissues. In comparing  the 
gels, we can find 7 spots in normal tissue which 
are eliminated or decreased from tumoral 
sample, these spots include A , B, C, D, E , F, 
and H. spot A is completely eliminated but it 
could be present to some extent in some samples 
due to having traces of normal tissue 
accompanying with tumoral ones. And 6 spots, 
B to H have decreased expression in tumoral 
tissue in comparison with normal tissue. 
According to figure 2, there are 7 spots in 
tumoral sample which existed or increased 
expression level in comparison with normal 
sample. The newly existed proteins in tumoral 
tissue nominated as tumor associated proteins. 
     These peptides are specific for tumoral 
tissues and have critical role in cancer 
development. These spots that are numbered 
from 1 to 4 are common in 70 % of cases and 
spots 5 to 7 had increased expression level in 
majority of tumoral samples (Figures 1 and 2). 
Some polypeptides which are expressed more in 
esophagus tissue could be seen as large and 
intense color spots. These kinds of spots have 
high expression levels and may cover other tiny 
spots in this area and we may lose some 
information about tiny expressing proteins in 
these points. 
Also some times tumoral tissue is accompanied 
with normal ones and we may recognize some 







Figure 1. A representative 2DE gel of a normal tissue. 
Proteins that become down-regulated in corresponding 
tumor are shown with arrows and capital letters 
 
 
Figure 2. A representative 2DE gel of tumor tissue. Arrows 
and numbers indicate up-regulated proteins in comparison 
with their matched normal tissue 
 
 
Protein recognition by mass spectrometry 
     Silver stained protein spots containing the 
proteins of interest were separated completely 
from gel and after adding acid acetic 5%, 
samples were used for mass spectrometry. By 
using MALDI/TOF/TOF system, amino acid 
sequences of the protein were recognized and 
similar spots were distinguished. 
 
Bioinformatic studies 
     Raw data for mass spectrometry were 
analyzed according to data banks' information. 
Information about a single protein included 
biological function, protein interactions, cellular 
position, first to third protein structure, specific 
ligands and its homology with different proteins 
(Table 2). 
Different data banks as listed below were used 
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846.4679 846.433 232 238 LKEAETR  
894.4679 894.4463 162 168 YEEVARK  
916.4734 916.4508 192 198 QLEEELR  
1107.5792 1107.5211 239 248 AEFAERSVAK  
1143.6116 1143.5856 190 198 ARQLEEELR  
1170.6727 1170.6464 169 178 LVILEGELER  
1243.6528 1243.6317 92 101 IQLVEEELDR  
1262.597 1262.5764 179 189 SEERAEVAESR  
1298.7677 1298.7423 168 178 KLVILEGELER  
1332.6389 1332.6127 78 90 ATDAEADVASLNR  
1343.6801 1343.6615 38 48 QLEEEQQALQK  
1399.7539 1399.7324 91 101 RIQLVEEELDR  
1443.8053 1443.7762 106 118 LATALQKLEEAEK  
1460.7339 1460.7119 77 90 KATDAEADVASLNR  
1471.775 1471.7477 38 49 QLEEEQQALQKK  
1488.74 1488.715 78 91 ATDAEADVASLNRR  
1493.7338 1493.7158 141 152 MELQEMQLKEAK Oxidation (M) 
1616.835 1616.8109 77 91 KATDAEADVASLNRR  
1671.8911 1671.8682 169 182 LVILEGELERSEER  
1702.8792 1702.8088 36 49 CKQLEEEQQALQKK  
1719.8582 1719.834 192 205 QLEEELRTMDQAL Oxidation (M) 
1727.8922 1727.8687 92 105 IQLVEEELDRAQER  
1799.9861 1799.9597 168 182 KLVILEGELERSEER  
1817.8776 1817.8594 153 167 HIAEDSDRKYEEVAR  
1883.9933 1883.9731 91 105 RIQLVEEELDRAQER  
1946.9963 1946.9734 190 205 ARQLEEELRTMDQALK Oxidation (M) 
2202.1248 2202.1091 106 125 LATALQKLEEAEKAADESER  
2414.252 2414.2375 169 189 LVILEGELERSEERAEVAESR  
2534.1636 2534.271 199 220 TMDQALKSLMASEEEYSTKEDK            
 
DISCUSSION 
     In esophagus cancer, less than 5% of patients 
survive more than 5 years of disease occurrence 
[25]. Two types of esophagus cancer are 
recognized: Adenocarcinoma, and squamous 
epithelial tissue. Etiology of adenocarcinoma is 
barrette phenomena which is caused by stomach 
acid reflection in esophagus and PH changes 
would lead to transformation of squamouse 
cells to cylindrical ones in the last one third 
length of esophagus. Most esophagus cancer 
cases in the world occur in Iran [26]. 
So recognition of molecular etiology of the 
disease is very important. Also finding 
molecular markers for early distinguish of the 
disease would be helpful in effective treatment 
and patients' surveillance. 
Most of the studies have been performed on 
esophagus adenocarcinoma, and researchers 
could recognize some molecular markers such 
as increased expression level of P53, PCNA, 
growth factors like epidermal growth factor 
(EGF) and its receptor (EGFR) and TGFα [27]. 
     But they cannot find any special marker for 
squamous epithelial cell carcinoma. These days, 
due to advances in technology, through using 
2D electrophoresis, recognition of specific 
markers related to this kind of disease is 
possible. Occurring in limited areas in the 
world, esophagus cancer has not been fully 
studied as other kinds of cancers have been. 
According to multistage nature of cancer, 
knowing initial changes would help a lot, for 
example, recognition of Barrette phenomena is 
a critical sign for initiation of esophagus cancer.  
In addition, besides barrette, some mutations in 
tumor suppressor genes like P53 and APC 
would happen [28]. Also, before cancer 
dysplasia in esophagus tissue would be an alarm 
for a serious case.  Cytopatological studies have 
been performed in Iran and also in Linxian area 
of China but molecular studies are undoubtedly 
essential in disease studies.  
   2D electrophoresis technique has been 
performed for lung [29], liver [30], and colon 
[31] cancers, and changes in protein expression, 
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elimination and existence of proteins in 
cancerous versus normal tissue were mentioned. 
These changes would occur in skeletal cell 
structure (morphology) protein function, cell 
proliferation and differentiation [32]. All of the 
studies have been performed for not only 
finding molecular etiology but also molecular 
markers for recognition of the disease (in 
polypeptide level) and follow up the progress of 
treatment. Among all these, decrease or 
elimination of E Cadherin is performed in 
esophagus cancer [33].  This protein has an 
essential role in morphogenesis, differentiation 
(especially in fetus), establishing polarity in 
fetus evolution and induction of early genes and 
connection and interaction between cells [34]. 
Decrease or deletion of Trp-B or its isoforms 
are being studied in this research and is 
categorize in changes which could be the 
subject of future studies. 
     This protein as a good molecular marker 
candidate preserves cytoskeleton cell structure 
and establishes involuntary esophagus motions 
with contraction mechanism [35]. Novel 
Progresses in proteomics and mass spectrometry 
will lead to find more specific and sensitive 
molecular markers for early distinguishing 
critical diseases as cancers. 
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Zia ée AA,Rastgar-Jazii F,Yazdanbod M, 
Kamangar F, Saidi F, Hainaut P. Distinct 
pattern of P53 mutation in squamous cell 
carcinoma of the esophagus in Iran. Oncogene 
2001; 20: 7368-7374. 
11. Laird PW, jaenisch R. DNA methylation 
and cancer. Human Molecular Genetics 1994; 
3:1487-1495. 
12. Fitzgerld D j, Yamasaki H. Tumor 
promotion: Models and assay systems, 
Teratogenesis. Carcinogenesis and Mutagenesis 
1990; 10: 89-102. 
13. Shields P E, Harris C C. Molecular 
epidemiology and the genetic of environmental 
cancer. The Journal of the American Medical 
Association (JAMA) 1991; 266:681-687. 
14. Liotta L A. Positive and negative molecular 
regulation ofinvasion and metastasis. Origin of 
Human Cancer, a Compregensive Review 1991; 
Sep; 833-843. 
15. Furcht L T. Tumor cell invasion, matrix 
metalloproteinase and the dogma. Laboratory 
Investigation 1994; 70:781-783. 
16. Stoner GD, Gupta A, Etiology and 
chemoprevention of esophageal squamous cell 
carcinoma. Carcinogenesis 2001; 22:1737-1746. 
17. Franzen B. A two dimensional gel 
electrophoresis study of proteins in tumors of 
the lung and breast. Stockholm: Repro Print 
AB; 1996. 10-18. 
18. Sipper J A, Reggia Roboter, die sich selbst 
vermehren. Spektrum der Wissenschaft, 
Scientific American 2002; April: 26-33.  
19. High Prevalence of Human Papillomavirus 
in squamous cell carcinoma and matched 
normal 
esophageal mucosa. Cancer 1995; 76: 1522-
1528. 
20. Berkelman T, Stenstedt. T. 2D-
Electrophoresis. Using Immobilized pH 
gradients. Technical University of Munich 
1998; 12: 1-54. 
 21. Bradford M M. A rapid and sensitive 
Journal of Paramedical Sciences (JPS)                    Summer 2010 Vol.1, No.3 ISSN 2008-496X 
_____________________________________________________________________________________________________________________________________________________________________________________                  
                                                                                                                                                           
16 
 
Method for the quantification of protein 
  utilizating the principle of protein-dye binding, 
Analytical Biochemistry 1976; 72:248-254 
22. Ofarell H P. High resolution 2DE of protein. 
The Journal of Biology Chemistry 1975;      
10:4007-4021 
23. Lameli U K. Cleavage of structural protein 
during the assembly of the head of 
bacteriophage T4. Nature 1970; 277:680-685. 
24.  Nesterenko M v, Tilley M, Upton S. A 
simple modification of   Blum’s silver stain 
method allows for 30 minute detection of 
proteins in polyacryamide gels. Biochem. 
Biophys. Methods 1999; 28: 239-242. 
25. Acharyya S, Ladnerr KJ, Nelsen LL, 
Damrauer J, Reiser PJ, Swoap S, Guttridge DC. 
Cancer   cachexia is regulated by selective 
targeting of skeletal muscle gene products. J 
Clin Invest 2004; 114: 370-378. 
26. Munoz N. Aspects of esophageal cancer. 
Endoscopy 1993; 25: supplement 609-612. 
27. Moskal TL, Huang S, Ellis LM, Fritsche 
HA, Chakrabarty S. Serum levels of 
transforming growth factor alpha in 
gastrointestinal cancer patients. Cancer 
Epidemiol Biomarkers Perv 1995; 4: 127-131. 
28. Zhuang Z, Li H, DeCamp D, Chen S, Shu 
H, Gong Y. Barrett’s esophagous: Metaplastic 
cells with loss of heterozygosity at the APC 
gene locus are clonal precursors to invasive 
adenocacinoma. Cancer Research 1996; 
56:1961-1964. 
29. Okazawa K, Chang C. Characterization of 
gene expression in clinical lung cancer material 
by two dimensional polyacrylamide gel 
electrophoresis. Electrophoesis 1994; 15: 382-
390. 
30. Writh P J. Two dimensionl polyacrylamide 
gel electrophoresis in exerimental 
hepatocarcinogenesis studies. Elestrophoresis 
1994; 15: 358-371. 
31. He QY, Chen J, Kung HF, Yuen AP, Chiu 
JF. Identification of tumor-associated proteins 
in oral tongue squamous cell carcinoma by 
proteomics. Proteomics 2004; 4: 271-278. 
32. Birchmeier W. E-cadherinas a tumor 
(invasion) suppressor gene. BioEssay 1995; 17: 
97-99. 
33. Mesaeli N, Phillipson C. Impaired p53 
expression, function, and nuclear localization in 
calreticulin-deficient cells. Mol Biol Cell 2004; 
15: 1862-1870. 
34. Marrs J A, Nelson W J. cadherin cell 
adhesion molecules in differentiation and 
embryogenesis. International Reviews of 
Cytology 1996; 163:159-205. 
35. Bakin AV, Safina A, Rinehart C, Daroqui C, 
Darbary H, Helfman DM. A critical role of 
tropomyosins in TGF-beta regulation of the 
actin cytoskeleton and cell motility in epithelial 
cells. Mol Biol Cell 2004; 15: 4682-4694. 
 
